CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $2.44M invested in Chemomab Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57.4K | |
| 2 | +$13.9K | |
| 3 | +$4.02K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.15K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$912 |
Top Sellers
| 1 | -$20.4K | |
| 2 | -$18K | |
| 3 | -$14.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.94K |
| 5 |
O
OrbiMed
New York
|
-$4 |